incomplete response
on 04 Oct 2024
Last Applicant/ Owned by
Tasocagi Yolu No:19/1 D:F Blok Bagcilar
Istanbul
TR
34100
Serial Number
97929646 filed on 10th May 2023
Registration Number
N/A
Correspondent Address
Nazly Aileen Bayramoglu
Filing Basis
No Filing Basis
Disclaimer
NO DATA
Systemic anti-infectives, namely, antiparasitic, antibacterial and antifungal pharmaceuticals; Musculo-skeletal system pharmaceutical products for the treatment of musculo-skeletal system diseases; Cardiovascular pharmaceuticals, namely, diuretics, lipid lowering agents, beta blocking agents, and calcium antagonists being calcium channel blockers; Pharmaceuticals for the prevention and treatment o Read More
Systemic anti-infectives, namely, antiparasitic, antibacterial and antifungal pharmaceuticals; Musculo-skeletal system pharmaceutical products for the treatment of musculo-skeletal system diseases; Cardiovascular pharmaceuticals, namely, diuretics, lipid lowering agents, beta blocking agents, and calcium antagonists being calcium channel blockers; Pharmaceuticals for the prevention and treatment of disorders of the nervous system, namely, pharmaceuticals in the nature of analgesics, psychoanaleptics, and psycoleptics for the treatment of psychosis, anti-epileptics for the treatment of epilepsy, central nervous system drugs being drugs for the treatment of central nervous system disorders, anaesthetics, antiparkinson preparations for the treatment of parkinson's disease, namely, antiparkinson pharmaceuticals; Pharmaceuticals for the treatment of respiratory diseases and asthma; Pharmaceuticals for the treatment of hormonal disorders and the prevention of osteoporosis; Anti-diabetic pharmaceuticals; insulins; Pharmaceuticals for the treatment of Alimentary Tract and Metabolism; Pharmaceuticals for the treatment of bone diseases and joint diseases; Pharmaceuticals for the treatment of blood and blood forming organs; Pharmaceuticals for the treatment of viral and infectious diseases; Pharmaceuticals for use as antineoplastic agents, namely, pharmaceuticals for the treatment of cancer; Pharmaceuticals for the treatment of immune system related diseases and disorders; Pharmaceuticals for the treatment of sensory organs; Pharmaceuticals for the treatment of kidney diseases; Pharmaceuticals for the treatment of erectile dysfunction; Pharmaceuticals for ophthalmological use
N/A
N/A
No 97929646
No Service/Collective Mark
No
No
No
Yes
Yes
No
No
No
No
Status Date | Action Taken |
---|---|
04th Oct 2024 | ABANDONMENT NOTICE E-MAILED - INCOMPLETE RESPONSE |
09th Sep 2024 | ABANDONMENT - INCOMPLETE RESPONSE |
29th Aug 2024 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
29th Aug 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
29th Aug 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
07th Jun 2024 | FINAL REFUSAL WRITTEN |
07th Jun 2024 | NOTIFICATION OF FINAL REFUSAL EMAILED |
07th Jun 2024 | FINAL REFUSAL E-MAILED |
09th May 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
09th May 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |